Portside Wealth Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.88M | Sell |
41,738
-2,814
| -6% | -$194K | 0.43% | 57 |
|
|
2025
Q1 | $3.09M | Sell |
44,552
-9,133
| -17% | -$634K | 0.5% | 56 |
|
|
2024
Q4 | $4.62M | Sell |
53,685
-5,330
| -9% | -$458K | 0.76% | 28 |
|
|
2024
Q3 | $7.03M | Buy |
59,015
+2,200
| +4% | +$262K | 1.2% | 17 |
|
|
2024
Q2 | $8.11M | Sell |
56,815
-336
| -0.6% | -$48K | 1.55% | 7 |
|
|
2024
Q1 | $7.34M | Sell |
57,151
-2,170
| -4% | -$279K | 1.36% | 11 |
|
|
2023
Q4 | $6.14M | Sell |
59,321
-3,514
| -6% | -$364K | 1.14% | 17 |
|
|
2023
Q3 | $5.71M | Buy |
62,835
+29,721
| +90% | +$2.7M | 1.07% | 21 |
|
|
2023
Q2 | $2.68M | Buy |
+33,114
| New | +$2.68M | 0.5% | 52 |
|